Advances in Nanopathology (Record no. 72836)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05120cam a2200553Mu 4500 |
| 001 - CONTROL NUMBER | |
| control field | 9781003056225 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220531132456.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210403s2021 xx o ||| 0 eng d |
| 040 ## - Cataloging Source | |
| -- | OCoLC-P |
| -- | eng |
| -- | OCoLC-P |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781000091786 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1000091783 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781003056225 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1003056229 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781000091755 |
| -- | (electronic bk. : Mobipocket) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1000091759 |
| -- | (electronic bk. : Mobipocket) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781000091724 |
| -- | (electronic bk. : PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1000091724 |
| -- | (electronic bk. : PDF) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1244625022 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC-P)1244625022 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RS201.N35 |
| 072 #7 - | |
| -- | MED |
| -- | 000000 |
| -- | bisacsh |
| 072 #7 - | |
| -- | MED |
| -- | 061000 |
| -- | bisacsh |
| 072 #7 - | |
| -- | SCI |
| -- | 050000 |
| -- | bisacsh |
| 072 #7 - | |
| -- | TBN |
| -- | bicssc |
| 082 04 - | |
| -- | 615.902 |
| -- | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gatti, Antonietta Morena. |
| 245 10 - TITLE STATEMENT | |
| Title | Advances in Nanopathology |
| Medium | [electronic resource] : |
| Remainder of title | From Vaccines to Food. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Milton : |
| Name of publisher, distributor, etc. | Jenny Stanford Publishing, |
| Date of publication, distribution, etc. | 2021. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (198 p.) |
| 500 ## - GENERAL NOTE | |
| General note | Description based upon print version of record. |
| 505 0# - | |
| -- | Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Contents -- Preface -- 1. Introduction -- 1.1 How Nanopathology Was Born -- 1.1.1 What Is Nanopathology? -- Appendix: Deep Vein Thrombosis and Caval Filtration -- 2. The Concept of Biocompatibility -- 2.1 Introduction -- 2.2 Particles in the Tissues -- 2.3 Biocompatibility and Nanotechnologies -- 2.4 How Particles Behave in the Body -- 2.5 Objections to Particle Theory -- 3. How Nanoparticles Are Generated -- 3.1 What Are Particles and How Are They Produced? -- 3.2 Waste: The Production of Incidental Nanoparticles |
| 505 8# - | |
| -- | 3.3 Diesel Particulate Filter -- 3.4 War and Terrorism -- 3.4.1 Depleted-Uranium Weapons -- 3.5 The Case of the World Trade Center -- 3.6 Engineered Nanoparticles and Nanotechnologies -- 3.7 How Particles Behave in the Environment -- 3.8 What Is Being Done to Prevent Particles from Entering the Environment? -- 3.8.1 Bag Filters -- 3.8.2 Urban Pollution Filters -- 4. Exposure to Air Pollution: How Particles Enter the Body -- 4.1 The Inhalation/Respiration Pathway -- 4.2 Particles and the Circulatory System -- 4.3 The Environment: Polluted Sites -- 4.4 The Aerotoxic Syndrome |
| 505 8# - | |
| -- | 4.5 Diffusion and Concentration of Particles -- 5. The Ingestion Pathway -- 5.1 Introduction -- 5.2 Vegetables -- 5.3 Meat and Fish -- 5.4 Engineered Particles in the Food -- 5.5 Drugs -- Appendix: Why Chelation Therapy Is Ineffective with Nanoparticles -- 6. The Injection Pathway and Other Entry Channels -- 6.1 Biocompatibility of What Is Introduced in the Body by Injection -- 6.2 Vaccines -- 6.3 Sudden Infant Death Syndrome -- 6.4 Sexually Transmissible Diseases by Particles -- 7. How Babies Can Be Polluted -- 7.1 Male Fertility, Burning Semen Disease and Endometriosis |
| 505 8# - | |
| -- | 7.2 Particles from Mother to Foetus -- 7.3 Drugs Administered during Pregnancy -- 7.4 Drugs Immediately after Birth -- 8. The Future -- 8.1 Particle Removal from Blood -- 8.2 Conclusions -- Index |
| 520 ## - | |
| -- | If observed from an objective, epistemological standpoint, medicine is not a science, at least not in its own right. The most important, key feature missing is repeatability, which makes the doctor's job extremely difficult. Doctors are not scientists but are called upon to use the results of scientific research every day. Therefore, they must keep themselves updated, distinguish what is worth extricating from a huge amount of literature and use the data exclusively in the patients' interest. To be effective, medicine must start from a correct, full understanding of problems, but particulate pollution leads to too many wrong diagnoses. This book, written by the discoverers of nanopathology, is the most advanced in the field. It focuses on how natural, occasionally generated, engineered particles interfere with living organisms, food, drugs and the environment. It represents a bridge between environmental pollution and its impact on human/animal/plant health. Also unique is its new bioengineering-interdisciplinary approach to medicine and solving pathologies of unknown aetiology. It is a valuable aid for medical doctors in their diagnoses of pathologies triggered by nanoparticles internalized in the human/animal/plant body. They will find solutions to some hardly understandable symptoms which some patients report. |
| 588 ## - | |
| -- | OCLC-licensed vendor bibliographic record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Nanoparticles. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Nanotechnology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pathology. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / General |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Occupational & Industrial Medicine |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | SCIENCE / Nanostructures |
| Source of heading or term | bisacsh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Montanari, Stefano. |
| 856 40 - | |
| -- | Taylor & Francis |
| -- | https://www.taylorfrancis.com/books/9781003056225 |
| 856 42 - | |
| -- | OCLC metadata license agreement |
| -- | http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
No items available.